Mortality Rates after Tuberculosis Treatment, Georgia, USA, 2008-2019

被引：0

作者：

Gorvetzian, Sarah ^{[1
,4
]}

Pacheco, Antonio G. ^{[2
]}

Anderson, Erin ^{[3
]}

Ray, Susan M. ^{[1
,3
]}

Schechter, Marcos C. ^{[1
,3
]}

机构：

[1] Emory Univ, Sch Med, Atlanta, GA USA

[2] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil

[3] Georgia Dept Publ Hlth, Atlanta, GA USA

[4] Univ Colorado, Anschutz Med Campus, Aurora, CO USA

来源：

EMERGING INFECTIOUS DISEASES | 2024年 / 30卷 / 11期

基金：

美国国家卫生研究院;

关键词：

DISEASE; GUIDELINES; SURVIVAL;

D O I：

10.3201/eid3011.240329

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Limited data exist on mortality rates after tuberculosis (TB) treatment in the United States. We analyzed mortality rates for all adults in Georgia, USA, who had a TB diagnosis and finished treatment during January 1, 2008-December 31, 2019. We obtained posttreatment mortality rate data from the National Death Index and calculated standardized mortality ratios (SMRs) for TB treatment survivors and the general Georgia population. Among 3,182 TB treatment survivors, 233 (7.3%) had died as of December 31, 2019. The overall TB cohort age- and sex-adjusted SMR was 0.89 (95% CI 0.73- 1.05). The SMR among US-born TB treatment survivors was 1.56 (95% CI1.36-1.77). In the TB cohort, US-born status, HIV co-infection, excess alcohol use, diabetes mellitus, and end-stage renal disease were associated with increased risk for death after TB treatment. TB treatment survivors could benefit from improved linkage to primary and HIV comprehensive care to prevent posttreatment death.

引用

页码：2261 / 2270

页数：10

共 41 条

[1] NEW LOOK AT STATISTICAL-MODEL IDENTIFICATION [J].

AKAIKE, H .

IEEE TRANSACTIONS ON AUTOMATIC CONTROL, 1974, AC19 (06) :716-723

[2]

[Anonymous], 7 Whether it is possible to use phylogenetic data to determine the transmission of HIV virus from one person to another is a matter of active contestation in the HIV community. CDC and an international cohort of experts on this topic insist that it not possible using currently available methods. However, some scholars and activists claim that the science behind this statement is immaterial in the hands of over-zealous actors. I explore aspects of this controversy in the pages that

[3]

Alexander McClelland, Adrian Guta, and Marilou Gagnon, "The Rise of Molecular HIV Surveillance: Implications on Consent and Criminalization," Critical Public Health, February 20, 2019, 1-7, https://doi.org/10.1080/09581596.2019.1582755

[4]

Martha Kempner, "New Study Triggers Concerns Over Use of Molecular HIV Surveillance," The Body Pro: The Complete HIV/AIDS Resource, March 4, 2019, http://www.thebodypro.com/content/ 81639/concerns-over-use-of-molecular-hiv-surveillance.html

[5]

HIV Prevention Policy Project, "Molecular HIV Surveillance: Engaging HIV Community Stakeholders to Examine the Promise and Risks from the New Technology (Conference Program)," June 14, 2018., DOI [10.26054/0D-8C1Z-7Z3S, 10.15479/AT:ISTA:18991]

[6]

[Anonymous], 2023, Chronological Table of U.S. Population Protected by 100% Smokefree State or Local Laws

[7]

[Anonymous], 262. Atlanta-The Georgia Department of Publ | Georgia Department of Public Health. Accessed May 21, 2021. https://dph.georgia.gov/press-releases/2020-05-12/atlantageorgia-department-publ

[8]

[Anonymous], National Center for Health Statistics Center for Disease Control and Prevention. [Available from: https://www.cdc.gov/nchs/].

[9]

[Anonymous], 2020, 10. Centers of Disease Control and Prevention. West Nile virus disease cases and deaths reported to CDC by year and clinical presentation, 1999-2019 [Internet]. Final cumulative maps data for 1999-2019. 2020 [cited 2021 Jan 3]. Available from: https://www.cdc.gov/westnile/statsmaps/cumMapsData.html#three

[10]

[Anonymous], 2013, National center for chronic disease prevention and health promotion: Diabetes public health source

← 1 2 3 4 5 →